ArticleCancer medicine2024

Long-Term Outcomes of Neoadjuvant Therapy Versus Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma.

Kyung In Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.